Stocks and Investing
Stocks and Investing
Tue, August 15, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, August 14, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Patrick Trucchio Maintained (ALT) at Strong Buy with Decreased Target to $15 on, Aug 14th, 2023
Patrick Trucchio of HC Wainwright & Co., Maintained "Altimmune, Inc." (ALT) at Strong Buy with Decreased Target from $50 to $15 on, Aug 14th, 2023.
Patrick has made no other calls on ALT in the last 4 months.
There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 0 agree with Patrick's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Patrick
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $15 on, Friday, August 11th, 2023
- Jonathan Wolleben of "JMP Securities" Reiterated at Buy and Held Target at $15 on, Wednesday, July 12th, 2023
Contributing Sources